Evidence map›Paper›PMID 26824024›Full record

ArticleTranslation (Austin, Tex.)2013

Clearance of yeast eRF-3 prion [PSI+] by amyloid enlargement due to the imbalance between chaperone Ssa1 and cochaperone Sgt2.

Chie Arai, Hiroshi Kurahashi, Chan-Gi Pack, Yasushi Sako, Yoshikazu Nakamura

Open access · bronzeAbstract read
In one paragraph

Article in Translation (Austin, Tex.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Chie AraiInstitute of Medical Science; University of Tokyo; Minato-ku, Tokyo, Japan; Department of Medical Genome Sciences; Graduate School of Frontier Sciences; The University of Tokyo; Chiba, Japan.
Hiroshi KurahashiInstitute of Medical Science; University of Tokyo; Minato-ku, Tokyo, Japan.
Chan-Gi PackCellular Informatics Laboratory; RIKEN Advanced Science Institute; Wako-shi, Saitama, Japan.
Yasushi SakoCellular Informatics Laboratory; RIKEN Advanced Science Institute; Wako-shi, Saitama, Japan.
Yoshikazu NakamuraInstitute of Medical Science; University of Tokyo; Minato-ku, Tokyo, Japan.
RIKEN Advanced Science Institute · JPThe University of Tokyo · JPJapan Institute for Advanced Dentistry · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cytoplasmic [PSI+] element of budding yeast represents the prion conformation of translation release factor eRF-3 (Sup35). Prions are transmissible agents caused by self-seeded highly ordered aggregates (amyloids). Much interest lies in understanding how prions are developed and transmitted. However, the cellular mechanism involved in the prion clearance is unknown. Recently we have reported that excess misfolded multi-transmembrane protein, Dip5ΔC-v82, eliminates yeast prion [PSI+]. In this study, we showed that the prion loss was caused by enlargement of prion amyloids, unsuitable for transmission, and its efficiency was affected by the cellular balance between the chaperone Hsp70-Ssa1 and Sgt2, a small cochaperone known as a regulator of chaperone targeting to different types of aggregation-prone proteins. The present findings suggest that Sgt2 is titrated by excess Dip5ΔC-v82, and the shortage of Sgt2 led to non-productive binding of Ssa1 on [PSI+] amyloids. Clearance of prion [PSI+] by the imbalance between Ssa1 and Sgt2 might provide a novel array to regulate the release factor function in yeast.

Indexed as

eRF-3GET pathwayHsp104HSRmisfolded multi-trans membranesprion clearance[PSI+]Sgt2Ssa1yeast prion

Identifiers

PMID26824024
PMCPMC4718058
OpenAlexW2066285577

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.